Related Experiment Video
Updated: Mar 22, 2026

Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
Large-leaf yellow tea oligosaccharides alleviate T2DM by promoting GLP-1 secretion and regulating intestinal mucosal
1State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Food and Nutrition, Joint Research Center for Food Nutrition and Health of IHM, Anhui Agricultural University, Hefei, Anhui 230036, China.
Background:
Glucagon-like peptide-1 (GLP-1), a key incretin produced by intestinal L-cells, plays a vital role in glucose and intestinal homeostasis during type 2 diabetes mellitus (T2DM) management. Large-leaf yellow tea polysaccharide (LYP) exhibits hypoglycemic effects, yet the structural features of LYP-derived bioactive oligosaccharides and their potential effects and mechanisms in promoting GLP-1 secretion remain unclear.
Purpose:
This study aimed to isolate an active oligosaccharide from LYP and explore its effects and underlying mechanisms on GLP-1 secretion and intestinal homeostasis in T2DM.
Methods:
An oligosaccharide (ELYP) was obtained from enzymatic degradation of LYP guided by activity evaluation. Its structure was characterized, and in situ intestinal perfusion was used to assess GLP-1 secretion in mice. Molecular mechanisms were explored in T2DM mice and STC-1 cells. Intestinal microorganisms and metabolites, intestinal barrier integrity, as well as immunocytes profiles were analyzed.
Results:
ELYP primarily consists of 1,4-linked β-GalpA and 1,4-linked β-Glcp, with degrees of polymerization between 3 to 7. It significantly increased plasma GLP-1 levels and upregulated genes related to GLP-1 synthesis, processing, and release synthesis and secretion. ELYP also restored intestinal barrier function by enhancing tight-junction proteins and goblet cell numbers, enriching beneficial gut microbiota and SCFAs composition, and promoting a transition of macrophages and T lymphocytes to an anti-inflammatory phenotype.
Conclusion:
ELYP effectively ameliorates T2DM by potently stimulating GLP-1 secretion and restoring intestinal homeostasis. This study not only identifies ELYP as a promising natural product for T2DM management but also provides new insights into the mechanism of tea-derived oligosaccharides.
More Related Videos
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Glucose Absorption Into the Small Intestine
Diabetes Mellitus: Type 2 and Gestational